Long-Term Digitalis Therapy in Heart Failure
- 23 April 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 304 (17) , 1043-1044
- https://doi.org/10.1056/nejm198104233041715
Abstract
To the Editor: The study of Arnold et al.1 on the hemodynamic actions of digitalis is welcome and long overdue. Although the theoretical basis of the use of digitalis has been subjected to more investigative scrutiny than that of any other drug in use at present, controlled clinical studies are almost nonexistent. This investigation, however, barely lifted one edge of the curtain separating us from an understanding of the clinical uses of the mysterious foxglove. The study raises many more questions than it answers.The first question, that of digitalis toxicity, is well evaluated in the editorial accompanying the article. . . .This publication has 7 references indexed in Scilit:
- Digitalis in cardiac failure. Do benefits justify risks?Archives of internal medicine (1960), 1981
- Withering RevisitedNew England Journal of Medicine, 1980
- Long-Term Digitalis Therapy Improves Left Ventricular Function in Heart FailureNew England Journal of Medicine, 1980
- The Natural History of Congestive Heart Failure: The Framingham StudyNew England Journal of Medicine, 1971
- The subcellular basis for the mechanism of inotropic action of cardiac glycosides.1971
- The epidemiology of cardiac failureJournal of Chronic Diseases, 1965
- Hemodynamic Effects of Digoxin in Latent Cardiac FailureCirculation, 1962